Deal of the Day — limited-time pharmacy picks!
Fibnib 150mg capsule

Fibnib 150mg capsule

Prescription requiredRx Required

Salt Composition: Nintedanib Soft Gelatin

Expiry Date: 01/2028

Special offer

Buy at $32.76

$32.76

Inclusive of all taxes

▼

10 capsule(s) in a strip

About The Product

PULMONARY FIBROSIS, LUNG FIBROSIS


Description

Fibnib 150mg capsule is an anticancer medication that is a part of Targeted Therapy. It is used to treat idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases with progressive features, systemic sclerosis-associated interstitial lung disease, and advanced non-small cell lung cancer (adenocarcinoma type)in combination with other medicine.

Fibnib 150mg capsule contains Nintedanib salt, that inhibits multiple pathways involved in Cancer cell growth and proliferation.​​

Uses

  • Idiopathic pulmonary fibrosis (IPF)

Side Effects

Fibnib 150mg capsule is an anticancer medication. Like any other medication it also has a range of side effects from mild to extreme. Talk to your doctor, if symptoms persist for longer period of time.  

  • Nausea
  • Vomiting
  • Fatigue
  • Diarrhea
  • Mouthy Sores
  • Headache
  • Fever
  • Anemia
  • Rashes
  • Muscle Cramps
  • Chest Pain

  • Peripheral Neuropathy
  • Unusual Bleeding
  • Kidney Dysfunction
  • Liver Dysfunction

How To Use

  • The standard or usual dosage of Fibnib 150mg capsule is two capsule daily, taken orally with food. Swallow the whole capsule as it is.
  • Avoid breaking, biting, chewing and crushing of capsule to maintain its efficacy. Dosage may vary based on the treatment, its stage and pateint's overall health.​​

How It Works

  • Fibnib 150mg capsule contains Nintedanib salt, that inhibits multiple pathways involved in Cancer cell growth and proliferation.
  • Nintedanib blocks the tyrosine kinase specific receptor such as VEGFR and FGFR. By inhibiting these kinases blood vessels formation is blocked. As a result, cancer cell growth stops.​​

Safety Advice

Alcohol

Alcohol consumption should be avoided during Fibnib 150mg capsule medication course. It can worsen the side effects of Kidney and Liver. Consult your doctor for more information on this

Pregnancy

Fibnib 150mg capsule is considered unsafe for pregnancy as it can cause potential threat to the developing baby. Please consult your doctor in such condition.

Breast Feeding

Breast Feeding is not advisable during Fibnib 150mg capsule course. Consult your Doctor for more information

Driving

It is advisable not to drive or operate any heavy machinery, as you may feel dizzy after taking Fibnib 150mg capsule

Kidney

Share your medical history related to kidney cancer or infection with your doctor before taking Fibnib 150mg capsule to adjust dosage

Liver

Notify your doctor about any liver disease or infection before starting Fibnib 150mg capsule course. As this medication can cause potential liver damage

FAQs

The common side effects of Fibnib 150mg capsule are nausea, headache, dizziness, fatigue, rashes, insomnia, abdominal pain etc.

References

  • Ghazipura, M., Mammen, M. J., Herman, D. D., Hon, S. M., Bissell, B. D., Macrea, M., ... & Hossain, T. (2022). Nintedanib in progressive pulmonary fibrosis: a systematic review and meta-analysis. Annals of the American Thoracic Society, 19(6), 1040-1049. https://pubmed.ncbi.nlm.nih.gov/35499854/
  • Mazzei, M. E., Richeldi, L., & Collard, H. R. (2015). Nintedanib in the treatment of idiopathic pulmonary fibrosis. Therapeutic advances in respiratory disease, 9(3), 121-129. https://pubmed.ncbi.nlm.nih.gov/25862013/
  • Barczi, E., Starobinski, L., Kolonics-Farkas, A., Eszes, N., Bohacs, A., Vasakova, M., ... & Müller, V. (2019). Long-term effects and adverse events of nintedanib therapy in idiopathic pulmonary fibrosis patients with functionally advanced disease. Advances in therapy, 36(5), 1221-1232. https://pubmed.ncbi.nlm.nih.gov/30877478/
  • Rangarajan, S., Kurundkar, A., Kurundkar, D., Bernard, K., Sanders, Y. Y., Ding, Q., ... & Thannickal, V. J. (2016). Novel mechanisms for the antifibrotic action of nintedanib. American journal of respiratory cell and molecular biology, 54(1), 51-59. https://pubmed.ncbi.nlm.nih.gov/26072676/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026